{"id":266088,"date":"2026-09-24T09:54:39","date_gmt":"2026-09-24T04:24:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=266088"},"modified":"2026-09-24T09:54:39","modified_gmt":"2026-09-24T04:24:39","slug":"why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/","title":{"rendered":"Kilitch Drugs (India) Ltd. (KILITCH): Kilitch Drugs Share Price near 52-week high; stock trades at Rs 225"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/kilitch\/kilitch-drugs-(india)-ltd-share-price-today\">Kilitch Drugs (India) Ltd. (KILITCH)<\/a> share price is trading within 2% of its 52-week high of Rs 233.5 today and later stood at Rs 225, up 0.51% from the previous close. Market cap was Rs 745.38 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Kilitch Drugs Share Price is trading at Rs 225, up 0.51% from the previous close, and remains near its 52-week high as of 24 September 2026 at 9:48 AM IST. The company\u2019s market capitalisation stands at Rs 745.38 crore, placing <a href=\"https:\/\/univest.in\/stocks\/kilitch\/kilitch-drugs-(india)-ltd-share-price-today\">Kilitch Drugs (India) Ltd.<\/a> in focus among healthcare names on Univest. The latest Univest figures show a session range between Rs 213 and Rs 233.5, with the stock last quoted below the day\u2019s high and above the previous close. On current evidence, the price event is clear, but the data does not establish a company-specific catalyst. For readers tracking Kilitch Drugs Share Price, the market is weighing a near yearly high move against valuation and sector benchmarks in the pharmaceuticals and drugs space.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Kilitch_Drugs_Share_Price_Today_Price_Action_Analysis\" title=\"Kilitch Drugs Share Price Today: Price Action Analysis\">Kilitch Drugs Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Kilitch_Drugs_India_Ltd_KILITCH_Fundamental_Analysis\" title=\"Kilitch Drugs (India) Ltd. (KILITCH) Fundamental Analysis\">Kilitch Drugs (India) Ltd. (KILITCH) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Why_Investors_Are_Watching_Kilitch_Drugs\" title=\"Why Investors Are Watching Kilitch Drugs\">Why Investors Are Watching Kilitch Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#About_Kilitch_Drugs\" title=\"About Kilitch Drugs\">About Kilitch Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Why_is_Kilitch_Drugs_Share_Price_near_its_52-week_high\" title=\"Why is Kilitch Drugs Share Price near its 52-week high?\">Why is Kilitch Drugs Share Price near its 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#What_is_Kilitch_Drugs_Share_Price_today\" title=\"What is Kilitch Drugs Share Price today?\">What is Kilitch Drugs Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#What_does_Kilitch_Drugs_Share_Price_News_show_about_valuation\" title=\"What does Kilitch Drugs Share Price News show about valuation?\">What does Kilitch Drugs Share Price News show about valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#How_does_Kilitch_Drugs_compare_on_return_ratios\" title=\"How does Kilitch Drugs compare on return ratios?\">How does Kilitch Drugs compare on return ratios?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#What_is_Kilitch_Drugs_market_cap\" title=\"What is Kilitch Drugs market cap?\">What is Kilitch Drugs market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#What_are_the_key_financial_figures_for_Kilitch_Drugs\" title=\"What are the key financial figures for Kilitch Drugs?\">What are the key financial figures for Kilitch Drugs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#How_does_Kilitch_Drugs_compare_with_healthcare_peers\" title=\"How does Kilitch Drugs compare with healthcare peers?\">How does Kilitch Drugs compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Where_can_I_track_Kilitch_Drugs_Share_Price_Live\" title=\"Where can I track Kilitch Drugs Share Price Live?\">Where can I track Kilitch Drugs Share Price Live?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-kilitch-drugs-india-ltd-share-price-near-52-week-high-today-2026\/#Track_Kilitch_Drugs_Share_Price_on_Univest\" title=\"Track Kilitch Drugs Share Price on Univest\">Track Kilitch Drugs Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Kilitch_Drugs_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Kilitch Drugs Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 225<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 223.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 1.15 (+0.51%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 233.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 233.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 213<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.11 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 745.38 crore<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:0!important;\">Kilitch Drugs (India) Ltd. (KILITCH) traded at Rs 225 versus the previous close of Rs 223.85, a rise of 0.51%. The stock opened at Rs 233.5, reached a high of Rs 233.5 and touched a low of Rs 213.<\/p>\n<p>Kilitch Drugs Share Price Today shows a modest intraday gain from Rs 223.85 to Rs 225, a change of Rs 1.15. The stock opened at Rs 233.5, matched the day\u2019s high at Rs 233.5, and touched a low of Rs 213 before trading at Rs 225. Turnover stood at Rs 0.11 crore. What happened today is straightforward: the share is holding near its 52-week high while trading within the day\u2019s range after opening above the last quoted level. For investors following Kilitch Drugs Share Price, the key takeaway is that the price event is intact, while the latest Univest data does not identify a stock-specific trigger. Kilitch Drugs Share Price News therefore remains centred on the price position and the nearby yearly high rather than on any stated catalyst.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Kilitch_Drugs_India_Ltd_KILITCH_Fundamental_Analysis\"><\/span><strong>Kilitch Drugs (India) Ltd. (KILITCH) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 745.38 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.78x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 8.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 80.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) fundamental metrics show P\/E 26.04x, P\/B 2.78x, ROE 12.26%, ROCE 14.5%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Kilitch Drugs (India) Ltd. has a market capitalisation of Rs 745.38 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 26.04x, P\/B at 2.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.26% and ROCE of 14.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 8.6, book value per share of Rs 80.45, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 28.44x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">42.34x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 762.66x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.78x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.32%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 745.38 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 777.84 crore<\/td>\n<\/tr>\n<\/table>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) has a P\/E ratio of 26.04x, which is below the benchmark median of 28.44x, a difference of -8.44%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) has a ROE of 12.26%, which is above the benchmark median of 11.69%, a difference of +4.88%. Kilitch Drugs (India) Ltd. (KILITCH) has a ROCE of 14.5%, which is above the benchmark median of 13.32%, a difference of +8.86%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/amanta\/amanta-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Amanta Healthcare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AMANTA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">732.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.23<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zimlab\/zim-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zim Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZIMLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">717.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">195.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.47<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/wanbury\/wanbury-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Wanbury Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">WANBURY<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">777.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">67.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">30.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/bafnaph\/bafna-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Bafna Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BAFNAPH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">793.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">103.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.87<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hexagon\/hexagon-nutrition-limited-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>HEXAGON NUTRITION LIMITED<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HEXAGON<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">804.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.37<\/td>\n<\/tr>\n<\/table>\n<p>Kilitch Drugs (India) Ltd. (KILITCH) has a P\/E ratio of 26.04x compared with the displayed peer median of 49.93x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.26% compares with a peer median of 12.27% across the companies shown in the table. ROCE stood at 14.5% versus the displayed peer median of 11.87%, providing a capital-efficiency comparison. Kilitch Drugs (India) Ltd. (KILITCH) has a market capitalisation of Rs 745.38 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Kilitch_Drugs\"><\/span><strong>Why Investors Are Watching Kilitch Drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Kilitch Drugs Share Price is trading at Rs 225, near its 52-week high, with a Rs 745.38 crore market cap.<\/li>\n<li>Kilitch Drugs Share Price Today shows a Rs 1.15 rise, or 0.51%, versus the previous close of Rs 223.85.<\/li>\n<li>The day\u2019s range spans Rs 213 to Rs 233.5, while turnover stands at Rs 0.11 crore.<\/li>\n<li>Kilitch Drugs Fundamental Analysis shows P\/E of 26.04, P\/B of 2.78, ROE of 12.26% and ROCE of 14.5%.<\/li>\n<li>Sector comparison places Kilitch Drugs below the industry median P\/E of 28.44 and above the ROE median of 11.69%.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Kilitch_Drugs\"><\/span><strong>About Kilitch Drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kilitch Drugs (India) Ltd. operates in the healthcare sector and the pharmaceuticals &amp; drugs industry. Kilitch Drugs Share Price is therefore tracked within a segment that is often assessed using valuation ratios, profitability metrics and benchmark comparisons. The company\u2019s latest published numbers include revenue figures, profit figures, EPS, book value and return ratios, which help frame Kilitch Drugs Share Price News in a measurable way. On Univest, this company profile sits alongside the market data that shapes Kilitch Drugs Share Price Today and broader Kilitch Drugs Stock Analysis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Kilitch_Drugs_Share_Price_near_its_52-week_high\"><\/span><strong>Why is Kilitch Drugs Share Price near its 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kilitch Drugs Share Price is trading at Rs 225, close to its 52-week high, with the latest market capitalisation at Rs 745.38 crore. the latest Univest figures confirm the price event but do not identify a company-specific trigger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Kilitch_Drugs_Share_Price_today\"><\/span><strong>What is Kilitch Drugs Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kilitch Drugs Share Price Today is Rs 225, up 0.51% from the previous close of Rs 223.85. The stock traded between Rs 213 and Rs 233.5 during the latest observed move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Kilitch_Drugs_Share_Price_News_show_about_valuation\"><\/span><strong>What does Kilitch Drugs Share Price News show about valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kilitch Drugs Share Price News shows a P\/E of 26.04 and a P\/B of 2.78. Those figures sit below the same-industry medians of 28.44 and 3, respectively, in the latest benchmark set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Kilitch_Drugs_compare_on_return_ratios\"><\/span><strong>How does Kilitch Drugs compare on return ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kilitch Drugs Share Price is backed by ROE of 12.26% and ROCE of 14.5%. Both are above the same-industry medians of 11.69% and 13.32%, which gives the stock useful benchmark context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Kilitch_Drugs_market_cap\"><\/span><strong>What is Kilitch Drugs market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kilitch Drugs Market Cap stands at Rs 745.38 crore. That is close to the same-industry median market capitalisation of Rs 777.84 crore, so the company sits near the middle of the benchmark range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_financial_figures_for_Kilitch_Drugs\"><\/span><strong>What are the key financial figures for Kilitch Drugs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kilitch Drugs Fundamental Analysis includes EPS of Rs 8.6, book value of Rs 80.45 and dividend yield of 0%. Revenue figures and profit figures are also available across recent reporting periods.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Kilitch_Drugs_compare_with_healthcare_peers\"><\/span><strong>How does Kilitch Drugs compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kilitch Drugs Share Price compares with peers such as Amanta Healthcare, Zim Laboratories, Wanbury, Bafna Pharmaceuticals and HEXAGON NUTRITION LIMITED. Its valuation sits in the middle of that peer set on the figures shown.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Kilitch_Drugs_Share_Price_Live\"><\/span><strong>Where can I track Kilitch Drugs Share Price Live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track Kilitch Drugs Share Price Live on Univest for price updates, market cap, financial ratios, revenue figures and peer comparisons. The platform also keeps the 52-week high context visible for quick reference.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Kilitch Drugs Share Price near its 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kilitch Drugs Share Price is trading at Rs 225, close to its 52-week high, with the latest market capitalisation at Rs 745.38 crore. the latest Univest figures confirm the price event but do not identify a company-specific trigger.\"}},{\"@type\":\"Question\",\"name\":\"What is Kilitch Drugs Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kilitch Drugs Share Price Today is Rs 225, up 0.51% from the previous close of Rs 223.85. The stock traded between Rs 213 and Rs 233.5 during the latest observed move.\"}},{\"@type\":\"Question\",\"name\":\"What does Kilitch Drugs Share Price News show about valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kilitch Drugs Share Price News shows a P\/E of 26.04 and a P\/B of 2.78. Those figures sit below the same-industry medians of 28.44 and 3, respectively, in the latest benchmark set.\"}},{\"@type\":\"Question\",\"name\":\"How does Kilitch Drugs compare on return ratios?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kilitch Drugs Share Price is backed by ROE of 12.26% and ROCE of 14.5%. Both are above the same-industry medians of 11.69% and 13.32%, which gives the stock useful benchmark context.\"}},{\"@type\":\"Question\",\"name\":\"What is Kilitch Drugs market cap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kilitch Drugs Market Cap stands at Rs 745.38 crore. That is close to the same-industry median market capitalisation of Rs 777.84 crore, so the company sits near the middle of the benchmark range.\"}},{\"@type\":\"Question\",\"name\":\"What are the key financial figures for Kilitch Drugs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kilitch Drugs Fundamental Analysis includes EPS of Rs 8.6, book value of Rs 80.45 and dividend yield of 0%. Revenue figures and profit figures are also available across recent reporting periods.\"}},{\"@type\":\"Question\",\"name\":\"How does Kilitch Drugs compare with healthcare peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kilitch Drugs Share Price compares with peers such as Amanta Healthcare, Zim Laboratories, Wanbury, Bafna Pharmaceuticals and HEXAGON NUTRITION LIMITED. Its valuation sits in the middle of that peer set on the figures shown.\"}},{\"@type\":\"Question\",\"name\":\"Where can I track Kilitch Drugs Share Price Live?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can track Kilitch Drugs Share Price Live on Univest for price updates, market cap, financial ratios, revenue figures and peer comparisons. The platform also keeps the 52-week high context visible for quick reference.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Kilitch_Drugs_Share_Price_on_Univest\"><\/span><strong>Track Kilitch Drugs Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/kilitch\/kilitch-drugs-(india)-ltd-share-price-today\">Kilitch Drugs (India) Ltd. (KILITCH) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>You can track Kilitch Drugs Share Price on Univest for live price updates, market cap, financial ratios, earnings figures, sector context, and the latest market insights. Univest also helps readers follow Kilitch Drugs Stock News, compare valuation with peers, and review the 52-week high context in one place.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kilitch Drugs (India) Ltd. Share Price trades near its 52-week high at Rs 225, marking a 0.51% rise today. Market cap stands at Rs 745.38 crore.<\/p>\n","protected":false},"author":29,"featured_media":266085,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-266088","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["266085"],"rank_math_title":["Kilitch Drugs Share Price near peak with P\/E, ROE and ROCE"],"rank_math_description":["Kilitch Drugs Share Price trades at Rs 225, near its 52-week high, with valuation, sector comparison and key fundamentals in focus."],"rank_math_focus_keyword":["Kilitch Drugs Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/kilitch-drugs-india-ltd-kilitch-kilitch-drugs-share-price-near-52-week-high.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/266088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=266088"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/266088\/revisions"}],"predecessor-version":[{"id":266091,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/266088\/revisions\/266091"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/266085"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=266088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=266088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=266088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}